These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 27678155)

  • 1. The D-form of a novel heparan binding peptide decreases cytomegalovirus infection in vivo and in vitro.
    Pitt EA; Dogra P; Patel RS; Williams A; Wall JS; Sparer TE
    Antiviral Res; 2016 Nov; 135():15-23. PubMed ID: 27678155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticytomegalovirus Peptides Point to New Insights for CMV Entry Mechanisms and the Limitations of
    Jackson JW; Hancock TJ; Dogra P; Patel R; Arav-Boger R; Williams AD; Kennel SJ; Wall JS; Sparer TE
    mSphere; 2019 Feb; 4(1):. PubMed ID: 30760613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo activity of 1-O-hexadecylpropanediol-3-phospho-ganciclovir and 1-O-hexadecylpropanediol-3-phospho-penciclovir in cytomegalovirus and herpes simplex virus infections.
    Hostetler KY; Rybak RJ; Beadle JR; Gardner MF; Aldern KA; Wright KN; Kern ER
    Antivir Chem Chemother; 2001 Jan; 12(1):61-70. PubMed ID: 11437323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Cytomegalovirus Replication with Extended-Half-Life Synthetic Ozonides.
    Wang Y; Mukhopadhyay R; Roy S; Kapoor A; Su YP; Charman SA; Chen G; Wu J; Wang X; Vennerstrom JL; Arav-Boger R
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30373792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effects by combination of ganciclovir and tricin on human cytomegalovirus replication in vitro.
    Yamada R; Suda H; Sadanari H; Matsubara K; Tuchida Y; Murayama T
    Antiviral Res; 2016 Jan; 125():79-83. PubMed ID: 26640224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subtherapeutic ganciclovir (GCV) levels and GCV-resistant cytomegalovirus in lung transplant recipients.
    Gagermeier JP; Rusinak JD; Lurain NS; Alex CG; Dilling DF; Wigfield CH; Love RB
    Transpl Infect Dis; 2014 Dec; 16(6):941-50. PubMed ID: 25491023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New inhibitors of cytomegalovirus replication: in vitro evaluation, mechanism of action, and in vivo activity.
    Neyts J; De Clercq E
    Verh K Acad Geneeskd Belg; 1994; 56(6):561-92. PubMed ID: 7892749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of ganciclovir-resistant human cytomegalovirus replication by Kampo (Japanese herbal medicine).
    Murayama T; Yamaguchi N; Iwamoto K; Eizuru Y
    Antivir Chem Chemother; 2006; 17(1):11-6. PubMed ID: 16542001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A common anti-cytomegalovirus drug, ganciclovir, inhibits HIV-1 replication in human tissues ex vivo.
    Vanpouille C; Bernatchez JA; Lisco A; Arakelyan A; Saba E; Götte M; Margolis L
    AIDS; 2017 Jul; 31(11):1519-1528. PubMed ID: 28657962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An in silico-designed flavone derivative, 6-fluoro-4'-hydroxy-3',5'-dimetoxyflavone, has a greater anti-human cytomegalovirus effect than ganciclovir in infected cells.
    Fujimoto KJ; Nema D; Ninomiya M; Koketsu M; Sadanari H; Takemoto M; Daikoku T; Murayama T
    Antiviral Res; 2018 Jun; 154():10-16. PubMed ID: 29559264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral monitoring and successful treatment of a ganciclovir-resistant cytomegalovirus infection in a heart transplant recipient.
    García-Martínez J; Folgueira L; Delgado R; Hernando S; Prieto C; Aguado JM; Otero JR
    Transpl Infect Dis; 2008 Apr; 10(2):123-8. PubMed ID: 17605746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide-derivatized dendrimers inhibit human cytomegalovirus infection by blocking virus binding to cell surface heparan sulfate.
    Luganini A; Giuliani A; Pirri G; Pizzuto L; Landolfo S; Gribaudo G
    Antiviral Res; 2010 Mar; 85(3):532-40. PubMed ID: 20083141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The discovery and development of filociclovir for the prevention and treatment of human cytomegalovirus-related disease.
    Hussein ITM; Brooks J; Bowlin TL
    Antiviral Res; 2020 Apr; 176():104710. PubMed ID: 31940473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effects of tricin derivative from Sasa albo-marginata on replication of human cytomegalovirus.
    Akuzawa K; Yamada R; Li Z; Li Y; Sadanari H; Matsubara K; Watanabe K; Koketsu M; Tuchida Y; Murayama T
    Antiviral Res; 2011 Sep; 91(3):296-303. PubMed ID: 21745500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ganciclovir-resistant cytomegalovirus infection in solid organ transplant recipients: a single-center retrospective cohort study.
    Young PG; Rubin J; Angarone M; Flaherty J; Penugonda S; Stosor V; Ison MG
    Transpl Infect Dis; 2016 Jun; 18(3):390-5. PubMed ID: 27037651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human cytomegalovirus double resistance in a donor-positive/recipient-negative lung transplant patient with an impaired CD4-mediated specific immune response.
    Baldanti F; Lilleri D; Campanini G; Comolli G; Ridolfo AL; Rusconi S; Gerna G
    J Antimicrob Chemother; 2004 Mar; 53(3):536-9. PubMed ID: 14739146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human induced pluripotent stem cells are resistant to human cytomegalovirus infection primarily at the attachment level due to the reduced expression of cell-surface heparan sulfate.
    Kawasaki H; Hariyama T; Kosugi I; Meguro S; Iwata F; Shimizu K; Magata Y; Iwashita T
    J Virol; 2024 Mar; 98(3):e0127823. PubMed ID: 38345384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ribonucleotide reductase inhibitors hydroxyurea, didox, and trimidox inhibit human cytomegalovirus replication in vitro and synergize with ganciclovir.
    Bhave S; Elford H; McVoy MA
    Antiviral Res; 2013 Oct; 100(1):151-8. PubMed ID: 23933116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent and persistent cytomegalovirus infection in a kidney recipient caused by the L595S mutation in UL97 phosphotransferase gene.
    Peixoto M; Mascarenhas L; Cunha A; Dutra M; Miranda E; Silva I; Costa S; Galvão B; Cunha A
    Antivir Ther; 2012; 17(3):585-8. PubMed ID: 22293247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human cytomegalovirus (HCMV) replication kinetics in stem cell transplant recipients following anti-HCMV therapy.
    Buyck HC; Griffiths PD; Emery VC
    J Clin Virol; 2010 Sep; 49(1):32-6. PubMed ID: 20667769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.